Search

Equillium Announces Three Abstracts Accepted for Presentation at the 104th AAI Annual Meeting

Presentations highlight the pathogenic role of the CD6-ALCAM pathway, the immunologic impact of modulating this pathway with itolizumab, and pharmacodynamic assays to monitor this in patients


https://ir.equilliumbio.com/news-releases/news-release-details/equillium-announces-three-abstracts-accepted-presentation-104th

Recent Posts

See All